Paradigm Biopharmaceuticals Limited announced that it has entered into a corporate partnership with NFL Alumni Health (NFLAH). This partnership will inform NFL Alumni Association (NFLAA) members about osteoarthritis disease onset and progression, current treatment options, and provide information about actively enrolling clinical trials throughout the U.S. The NFLAA has over 10,000 members and represents former NFL players, coaches, executives, spouses, cheerleaders, and associate members through its 40 chapters across the U.S. NFL Alumni Health is a wholly owned subsidiary of NFLAA offering informational resources, programs, services, and other benefits to NFLAA members and the general public. This division of the NFLAA appraises corporate partners that may provide beneficial research opportunities in health areas relevant to their members.

NFL Alumni Health oversee the vetting process to ensure they bring credible and meaningful health sector-related partnerships to their membership. Paradigm's designation as NFLAH's newest corporate and research partner demonstrates its leading role in developing a safe and effective potential treatment for those suffering with OA.